Screener
Jade Biosciences JBIO Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from investing activities: | ||
| Purchases of investments | (73,898) | — |
| Proceeds from sales/maturities of investments | 65,428 | — |
| Net cash used in investing activities | $(8,470) | — |
| Cash flows from financing activities: | ||
| Payment of deferred offering costs | — | (700) |
| Issuance costs from the December PIPE Financing | (809) | — |
| Issuance costs from the October PIPE Financing | (31) | — |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's investing cash flow?
- Jade Biosciences (JBIO) reported investing cash flow of -$8.47M in Q1 2026.
- How has Jade Biosciences's investing cash flow changed year-over-year?
- Jade Biosciences's investing cash flow decreased by 165.9% year-over-year, from $12.85M to -$8.47M.
- What is the long-term trend for Jade Biosciences's investing cash flow?
- Over 2 years (2021 to 2025), Jade Biosciences's investing cash flow has grown at a 47.6% compound annual growth rate (CAGR), from -$113.43M to -$247.01M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Jade Biosciences's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude